Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage studyThe data adds to mounting evidence that Zepbound and other popular GLP-1 drugs have health benefits beyond promoting weight loss and regulating blood sugar.[Collection]
The data adds to mounting evidence that Zepbound and other popular GLP-1 drugs have health benefits beyond promoting weight loss and regulating blood sugar.https://www.cnbc.com/2024/08/01/eli-lilly-weight-loss-drug-zepbound-cuts-heart-failure-risks-in-study.html
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment